Journal of Human Hypertension

Papers
(The H4-Index of Journal of Human Hypertension is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Covid-19 and the cardiovascular system: a comprehensive review221
COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society56
Hypertension in China: burdens, guidelines and policy responses: a state-of-the-art review50
Salt sensitivity and hypertension47
Indian guidelines on hypertension-IV (2019)46
Left ventricular remodeling and dysfunction in primary aldosteronism41
Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease37
A historical perspective on ACE2 in the COVID-19 era35
Recent advances in modulation of cardiovascular diseases by the gut microbiota34
Association of triglyceride-glucose index and its interaction with obesity on hypertension risk in Chinese: a population-based study29
Primary aldosteronism is a public health issue: challenges and opportunities28
SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives27
Diet-related gut microbial metabolites and sensing in hypertension25
Sex steroids receptors, hypertension, and vascular ageing24
Wearable blood pressure measurement devices and new approaches in hypertension management: the digital era24
Hypertension management in cardio-oncology23
Blood–brain barrier dysfunction: the undervalued frontier of hypertension23
COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute?22
Vitamin D deficiency in African Americans is associated with a high risk of severe disease and mortality by SARS-CoV-220
The mineralocorticoid receptor—an emerging player in metabolic syndrome?20
0.062094926834106